XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded.
Open original source
Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded.
Open original source